Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of DNK-651 Intradermal vs Subcutaneous in Japanese Participants ≥13 Years
jRCT2080223664Phase 2
- Sponsor
- Denka
- Start
- Sep 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of DNK-651 in Infectious disease (2 arms), sponsored by Denka.
02
Drugs
DNK-651
03
Conditions
Infectious disease
Beyond the preview
Go deeper on jRCT2080223664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223664.